Show simple item record

Assessing response to chemotherapy in metastatic melanoma with FDG PET: Early experience

dc.contributor.authorHofman, Michael S.en
dc.contributor.authorConstantinidou, Anastasiaen
dc.contributor.authorAcland, Katharine M.en
dc.contributor.authorHealy, Ciaranen
dc.contributor.authorHarries, Marken
dc.contributor.authorO'Doherty, M.en
dc.creatorHofman, Michael S.en
dc.creatorConstantinidou, Anastasiaen
dc.creatorAcland, Katharine M.en
dc.creatorHealy, Ciaranen
dc.creatorHarries, Marken
dc.creatorO'Doherty, M.en
dc.date.accessioned2018-06-22T09:53:37Z
dc.date.available2018-06-22T09:53:37Z
dc.date.issued2007
dc.identifier.urihttps://gnosis.library.ucy.ac.cy/handle/7/41938
dc.description.abstractThe management of metastatic melanoma remains challenging with only modest response rates to chemotherapy but the need to identify the best re-staging techniques remains paramount. This study evaluates our early experience in the use of FDG PET-CT in the assessment of early response to chemotherapy in metastatic melanoma. © 2007 Lippincott Williams & Wilkins, Inc.en
dc.language.isoengen
dc.sourceNuclear medicine communicationsen
dc.subjectFluorodeoxyglucoseen
dc.subjectPositron emission tomographyen
dc.subjectResponse assessmenten
dc.subjectFdgen
dc.subjectMetastatic melanomaen
dc.titleAssessing response to chemotherapy in metastatic melanoma with FDG PET: Early experienceen
dc.typeinfo:eu-repo/semantics/article
dc.description.volume28
dc.description.issue12
dc.description.startingpage902
dc.description.endingpage906
dc.author.facultyΙατρική Σχολή / Medical School
dc.author.departmentΙατρική Σχολή / Medical School
dc.type.uhtypeArticleen
dc.contributor.orcidConstantinidou, Anastasia [0000-0001-5316-7574]
dc.contributor.orcidHofman, Michael S. [0000-0001-8622-159X]
dc.gnosis.orcid0000-0001-5316-7574
dc.gnosis.orcid0000-0001-8622-159X


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record